RxDoctor Payments Data

Douglas Anderson, MD

Otolaryngology · Ogden, UTNPI 1790898807

Payments from drug & device makers

What this record shows

It is spread thinly across 24 manufacturers, the largest accounting for just 22.2%. 2025 is the largest year on record at $3,072, 2.8 times the $1,112 reported in 2019. Among otolaryngology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,848in general payments, 2019–2025

Across 202 payments — averaging $43.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Smith+Nephew$2K
  • Stryker$2K
  • Medical Device Business Services, Inc.$750
  • Optinose US, Inc.$407
  • Regeneron Healthcare Solutions, Inc.$401
  • plus $2K from 18 others
$34,895in research payments, 2019–2025

Across 28 payments — averaging $1246.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$29K
  • Smith+Nephew$5K

What the payments were for

  • Travel & lodging$4,11346%
  • Food & beverage$4,73554%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,848 in reported general payments places this provider in the 90th percentile of 104 otolaryngology providers in Utah.

See all otolaryngology providers in Utah

Medicare billing

Part B allowed, 2024
$70,266
Medicare patients
207
Services billed
857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CefuroximeCefuroxime Axetil61$700
Fluticasone Propionate24$345
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$298
Ofloxacin12$255
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$177
Omeprazole11$73
Azithromycin20$70
Amoxicillin16$58

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →